Tesamorelin carries the strongest regulatory standing it is an FDA-approved drug (Egrifta) and can also be compounded for off-label use under physician prescription
Oxbryta lawsuits typically arise from allegations that the drug caused unforeseen side effects or complications not adequately disclosed by the manufacturer
Your microbiome plays a major role in GLP-1 signaling, metabolism, and weight regulation
Studies have demonstrated that FOXO4-DRI modulates multiple regulatory pathways, including insulin signaling, cell cycle control, and oxidative stress response
Growth hormone regulation of p85alpha expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance
In the STEP 4 trial, participants who stopped semaglutide regained about two-thirds of the weight they had lost within one year (STEP 4 withdrawal study)